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Abstract
Introduction Factors predictive of the need for red blood cell
(RBC) transfusion in the intensive care unit (ICU) have been
identified, but risk factors for transfusion after ICU discharge are
unknown. This study aims identifies risk factors for RBC
transfusion after discharge from the ICU.
Methods A prospective, monocentric observational study was
conducted over a 6-month period in a 24-bed medical ICU in a
French university hospital. Between June and December 2003,
550 critically ill patients were consecutively enrolled in the
study.
Results A total of 428 patients survived after treatment in the
ICU; 47 (11% of the survivors, 8.5% of the whole population)
required RBC transfusion within 7 days after ICU discharge.
Admission for sepsis (odds ratio [OR] 341.60, 95% confidence
interval [CI] 20.35–5734.51), presence of an underlying
malignancy (OR 32.6, 95%CI 3.8–280.1), female sex (OR 5.4,
95% CI 1.2–24.9), Logistic Organ Dysfunction score at ICU
discharge (OR 1.45, 95% CI 1.1–1.9) and age (OR 1.06, 95%
CI 1.02–1.12) were independently associated with RBC
transfusion after ICU stay. Haemoglobin level at discharge
predicted the need for delayed RBC transfusion. Use of
vasopressors (OR 0.01, 95%CI 0.001–0.17) and haemoglobin
level at discharge from the ICU (OR 0.02, 95% CI 0.007–0.09;
P < 0.001) were strong independent predictors of transfusion
of RBC 1 week after ICU discharge.
Conclusion Sepsis, underlying conditions, unresolved organ
failures and haemoglobin level at discharge were related to an
increased risk for RBC transfusion after ICU stay. We suggest
that strategies to prevent transfusion should focus on
homogeneous subgroups of patients and take into account
post-ICU needs for RBC transfusion.
Introduction
Anaemia is a common feature in critically ill patients. In the
recent ABC study [1], haemoglobin level at admission was
below the normal range in 63% of patients admitted to the
intensive care unit (ICU). A low haemoglobin level is associ-
ated with poor prognosis in critically ill patients [1,2], as was
previously described in elderly patients with acute myocardial
infarction [3].
Because anaemia commonly occurs in the ICU, red blood cell
(RBC) transfusion is a frequent practice in the management of
critically ill patients to compensate for acute bleeding and to
increase tissue oxygen delivery [4]. Canadian and European
surveys reported that up to 40% of the patients admitted to
the ICU receive at least one RBC transfusion [1,5,6]. How-
ever, RBC transfusion carries short-term and long-term side
effects, and liberal transfusion strategies have been associ-
ated with a worse outcome in ICU patients [6]. In an effort to
avoid unnecessary RBC transfusion, intensivists have defined
haemoglobin thresholds above which transfusion appears
harmful [7-9]. They also proposed the use of erythropoietin
[10] to avoid RBC transfusion. Although these measures may
decrease blood transfusion in the ICU, they could have the
opposite effect on need for transfusion after the ICU stay.
Indeed, anaemia often persists or worsens after ICU discharge
[1]. The ABC study [1] clearly identified the frequent need for
post-ICU RBC transfusion, because 12.7% of patients who
enrolled needed RBC transfusion after their ICU stay.
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Whether efforts to limit blood transfusion in the ICU just delay
administration of RBC to the post-ICU period is unclear. In
addition, although predictive factors for the need for RBC
transfusion in the ICU have been identified [1,6,11], risk fac-
tors for transfusion after ICU discharge are unknown. We con-
ducted this prospective monocentric observational study to
identify risk factors for RBC transfusion in critically ill patients
after discharge from the ICU.
Materials and methods
Patients and method
After approval had been granted by our institutional ethics
committee and once informed consent had been given, we
enrolled every patient admitted to our medical ICU between 1
June 2003 and 1 December 2003. The following factors were
recorded for each patient on admission to the ICU: age, sex,
haemoglobin level, Simplified Acute Physiology Score II [12]
and Logistic Organ Dysfunction (LOD) score [13], past medi-
cal history (pulmonary disease, malignancy, cardiac disease,
diabetes mellitus, thromboembolic disease, significant renal
disease, haematological disorder) and cause of admission to
the ICU. The use of mechanical ventilation, noninvasive venti-
lation, vasoactive drugs (adrenaline [epinephrine], noradrena-
line [norepinephrine], dobutamine, dopamine above 5 µg/kg
per min), renal replacement therapy, erythropoietin and trans-
fusion of RBCs were also recorded, as was the length of the
ICU stay and ICU outcome. All patients received standard crit-
ical care, and the decision regarding transfusion of RBCs was
left to the judgement of the responsible physician. Finally,
transfusion of RBCs within 7 days after ICU discharge, in-hos-
pital length of stay following ICU discharge, and hospital out-
come were also recorded. Patients were followed up until
hospital discharge.
Statistical analysis
Categorical variables are presented as values (percentage)
and continuous variables as mean ± standard deviation. The
odds ratios (OR), 95% confidence intervals (CI) and P values
were calculated with exact tests for categorical data. We per-
formed χ2 tests or, when appropriate, Fisher's exact tests to
assess differences between proportions with calculations of
ORs and exact 95% CI. A P value below 0.05 was considered
statistically significant.
We examined the characteristics of patients discharged from
the ICU, and investigated their association with transfusion of
RBCs within 7 days. We compared patients who required
transfusion of RBCs (group I) with those who did not receive
any transfusion within 1 week after discharge (group II). Com-
parison between these two groups was performed with Stu-
dent's  t-test or χ2  analysis, as appropriate. Variables
significantly associated with the use of transfusion of RBCs
were incorporated into a stepwise logistic regression model in
which the transfusion of RBC within a week after ICU dis-
charge was the dependent outcome. The model was refined
Table 1
Patients' characteristics and outcome
Characteristic/outcome Value/details
Male 313 (56.9%)
Age (years) 52 (18.5)
SAPS II 39.7 ± 20.6
LOD score at ICU admission 4.2 ± 3.4
Medical history
Cardiac disease 131 (23.8%)
Pulmonary disease 130 (23.6%)
Diabetes 49 (8.9%)
Hypertension 76 (13.8%)
Malignancy 64 (11.6%)
Thromboembolic disease 28 (5.1%)
Renal disease 46 (8.4%)
Haematologic disorder 46 (8.4%)
Purpose of admission
Cardiac disorder 95 (17.3%)
Neurological disorder 93 (16.9%)
Respiratory disorder 140 (25.5%)
Poisoning 52 (9.5%)
Sepsis 79 (14.4%)
Haemorrhage 38 (6.9%)
Miscellanous 59 (10.7%)
Haemoglobin level on admission (g/dl) 11.4 ± 2.5
Treatment provided in the ICU
Mechanical ventilation 304 (55.3%)
Noninvasive ventilation 188 (34.2%)
Renal replacement therapy 86 (15.6%)
Vasoactive drug 188 (34.2%)
Erythropoietin 3 (0.5%)
ICU RBC transfusion 111 (20%)
Haemoglobin level on ICU discharge (g/dl) 10.6 ± 2.3
LOD score on ICU discharge 4 ± 6.4
RBC transfusion within 7 days after ICU 
discharge
47 (9%)
Mortality
ICU 122 (22%)
In-hospital 154 (28%)
Length of stay
ICU 6.07 ± 6.93
In-hospital 14.9 ± 12.15
Results are expressed as number (percentage) or mean ± standard 
deviation. ICU, intensive care unit; LOD, Logistic Organ Dysfunction; 
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by means of stepwise selection in which a P value below
0.001 was used as a criterion for inclusion in the model and a
P value above 0.01 was used as the threshold for removal from
the model.
Results
During the study period, we enrolled 550 consecutive patients
who were admitted to our ICU (Table 1). Most patients
(90.2%) were admitted for medical diagnosis, whereas the
remaining patients were admitted for emergency (7.3%) and
elective (2.5%) surgery. The overall mortality rate was 22%
(122 patients). Mean haemoglobin level on admission was
11.4 ± 2.5 g/dl. Twenty per cent of the population received
RBCs during their stay in the ICU. Mean haemoglobin at dis-
charge was 10.3 ± 2.3 g/dl. Forty-seven out of the 428
patients discharged from the ICU received RBC transfusion
within 1 week after discharge (group I) whereas 381 remained
free from transfusion at 1 week (group II). Hospital mortality
rates did not differ between the two groups.
Characteristics that differed between the groups are summa-
rized in Table 2. Patients from group I were older and predom-
inantly female. Patients were more likely to receive transfusion
after ICU discharge if they were admitted for sepsis, or had
hypotension or a medical history of malignancy. Patients
admitted to the ICU for a respiratory disorder or drug poison-
ing were significantly less transfused than others. Severity
scores on admission and discharge were higher among post-
ICU transfused patients (Table 2). However, patients with
haemodynamic instability requiring vasopressors surprisingly
required less RBC transfusion. The mean haemoglobin level at
admission in patients who received RBC transfusion within a
week after ICU discharge was 8.6 g/dl. Haemoglobin level on
admission and, as expected, at discharge from ICU was lower
among post-ICU transfused patients.
We performed a multiple logistic regression analysis to deter-
mine variables independently associated with increased risk
for RBC transfusion after ICU discharge (Table 3). Admission
for sepsis (OR 341.60, 95% CI 20.35–5734.51), presence of
an underlying malignancy (OR 32.6, 95% CI 3.8–280.1),
female sex (OR 5.4, 95% CI 1.2–24.9), LOD score at ICU dis-
charge (OR 1.45, 95% CI 1.1–1.9) and age (OR 1.06, 95%
CI 1.02–1.12) were independently associated with RBC
transfusion after ICU stay. The use of vasopressors (OR 0.01,
95%CI 0.001–0.17) and haemoglobin level at discharge from
Table 2
Main differences between and survival rates in patients discharged from the ICU
RBC transfusion (n = 47) No RBC transfusion (n = 381) P valuea
Female 33 (70%) 174 (46%) 0.038
Age (years) 55.3 ± 18.9 50.4 ± 18.4 0.021
Medical history
Respiratory disease 5 (11%) 107 (28%) 0.010
Hypertension 11 (23%) 48 (13%) 0.043
Malignancy 13 (28%) 35 (9%) <0.001
Diagnosis of admission
Pulmonary disease 1 (2) 115 (28) <0.001
Poisoning 0 (0) 49 (13) 0.009
Sepsis 18 (38) 43 (11) <0.001
SAPS II 40.1 ± 11 33.2 ± 16.1 0.004
LOD score on admission 4.0 ± 2.3 3.1 ± 2.8 0.047
LOD score at ICU discharge 1.7 ± 1.5 0.6 ± 1.6 <0.001
Treatment provided in the ICU
Vasoactive drugs 18 (38) 89 (23) 0.026
Haemoglobin level on admission (g/dl) 8.6 ± 1.2 11.8 ± 2.4 <0.001
Haemoglobin level at ICU discharge (g/dl) 7.5 ± 0.8 11.2 ± 2.0 <0.001
Length of stay in the ICU (days) 4.8 ± 3.0 5.4 ± 6.2 0.047
In-hospital outcome
Alive 43 (91) 353 (93) 0.56
Data are expressed as number (percentage) or mean ± standard deviation. aDependent two-tailed t-test. ICU, intensive care unit; LOD, Logistic 
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the ICU (OR 0.02, 95% CI 0.007–0.09; P < 0.001) were
strong independent predictors of transfusion of RBCs 1 week
after ICU discharge.
Discussion
We performed the present prospective study specifically to
evaluate the need for RBC transfusion during the post-ICU
period. We observed that 9% of critically ill patients treated in
a medical ICU required RBC transfusion after ICU discharge,
and that few parameters influenced need for transfusion of
RBCs within 7 days after the ICU stay.
Of patients discharged from the ICU, 11% (8.5% of the whole
cohort) required RBC transfusion after ICU discharge. This is
consistent with the findings of the ABC study [1], in which
RBC transfusion after ICU discharge occurred in 12.7% of the
population. In the present study, a considerable proportion of
the patients were surgical, and this might have influenced the
need for RBC transfusion.
Our study revealed that only few parameters influenced the
risk for transfusion of RBCs after ICU discharge. Haemoglobin
level at admission is a well established risk factor for transfu-
sion of RBCs during the ICU stay [1,9]. We found that haemo-
globin level on ICU admission was inversely correlated with
the risk for transfusion in univariate analysis but not in the mul-
tivariate model. Conversely, haemoglobin level at ICU dis-
charge markedly influenced requirement for RBC transfusion
during the 7 days following ICU discharge. In our study, a 1 g/
dl decrease in haemoglobin level increased by 50-fold the risk
for RBC transfusion during the post-ICU stay. Previous stud-
ies demonstrated that age was strongly associated with anae-
mia in the critically ill. In the ABC study [1] the mean
haemoglobin level at admission was significantly lower in
patients older than 90 years than in patients younger than 50
years (9.9 g/dl versus 11.7 g/dl). In addition, older patients
received more transfusions. We also observed a 1.06-fold
increase in the likelihood of RBC transfusion for each addi-
tional year. This could be explained by an increased incidence
of co-morbidities. Indeed, elderly patients frequently present
with coronary artery diseases for which haemoglobin thresh-
old values for transfusion are not clearly defined [9,14]. How-
ever, neither a previous medical history of heart disease nor
cardiac disorder as the cause of admission emerged as a risk
factor in our analysis. Conversely, we found that the presence
of an underlying malignancy was an independent risk factor for
RBC transfusion after ICU discharge. Solid neoplastic dis-
eases occur frequently in the elderly. It is well known that they
are responsible for anaemia and that their specific treatments
have myelotoxic effects. The ABC study [1] also found a
decreased haemoglobin level in patients who had a previous
history of anaemia, especially in the setting of neoplastic
disorder.
One of the most important factors associated with post-ICU
transfusion of RBC was sepsis as an admission diagnosis. A
previous study reported that septic patients had decreased
haemoglobin levels as compared with the remainder of the
ICU population [11]. Sepsis could impair production of eryth-
ropoietin by several mechanisms, including release of proin-
flammatory mediators that negatively impact erythropoiesis
[6,15]. We recently reported that sepsis can induce anaemia
by increased apoptosis of bone marrow erythroid progenitors
[16]. The severity of sepsis could also lead to a greater volume
of blood sampling for laboratory analysis in these patients [11].
Sepsis is frequently associated with organ failure. Whereas
severity scores at admission (Simplified Acute Physiology
Score II and LOD score) were reported as risk factors for ICU
transfusion, they did not influence the need for transfusion
after the ICU stay. On the other hand, a higher LOD score at
ICU discharge was related to increased risk for RBC transfu-
sion after the ICU stay (OR = 1.45 for each additional LOD
point). Patients with persisting organ dysfunctions on ICU dis-
charge more frequently required RBC transfusion during the
remainder of their hospital stay. Surprisingly, we observed that
use of vasopressors decreased the risk for RBC transfusion.
The reasons for this finding are unclear. No patient had haemo-
dynamic instability or was receiving ongoing vasopressor ther-
apy at ICU discharge.
Our study has some limitations. First, no specific guidelines
regarding RBC transfusion were given to the physicians
involved in patient care after the ICU stay. Variations in the
transfusion thresholds as well as in iron and vitamin supple-
mentation policies in the various medical wards might have
affected our results. Second, we limited the evaluation period
to the first 7 days following ICU discharge to ascertain
whether RBC requirement was directly related to the ICU stay.
This delay was chosen bearing in mind the natural history of
haematological disorders and the time course of myelotoxicity
of drugs used in the ICU. Although we acknowledge that the
Table 3
Multiple logistic regression analysis of predictive factors for 
RBC transfusion within 7 days after ICU discharge
Parameters OR (95% CI)
Sepsis 341.6 (20.3–5734.5)
Medical history of malignancy 32.6 (3.8–280.1)
Female sex 5.4 (1.2–24.9)
LOD score at ICU dischargea 1.45 (1.1–1.9)
Ageb 1.06 (1.02–1.12)
Vasopressors 0.01 (0.001–0.17)
Haemoglobin level on ICU dischargec 0.02 (0.007–0.09)
aOR adjusted for 1 point.bOR adjusted for 1 year. cOR adjusted for 1 
g/dl. CI, confidence interval; ICU, intensive care unit; LOD, Logistic 
Organ Dysfunction; OR, odds ratio; RBC, red blood cell.Available online http://ccforum.com/content/10/5/R129
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validity of a 7-day period of observation is debatable, selection
of the optimal follow-up period remains difficult because no
study has specifically adressed this issue.
Conclusion
Our study suggests that sepsis, underlying conditions, unre-
solved organ failures and haemoglobin level at discharge are
related to a increased risk for RBC transfusion after ICU stay.
Most of these findings are consistent with previous studies
that addressed the risk for transfusion in the ICU. These find-
ings should be considered when defining transfusion guide-
lines, because a higher haemoglobin level may be required in
specific subgroups of ICU patients. We suggest that any strat-
egy to prevent transfusion in the ICU should focus on homo-
geneous subgroups of patients and take into account post-
ICU needs for RBC transfusion.
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Key messages
•  Nine per cent of critically ill patients treated in a medical 
ICU require RBC transfusion after ICU discharge when 
strict transfusion guidelines are applied in the medical 
ICU.
• Sepsis,  underlying  conditions, unresolved organ failures 
and haemoglobin level at discharge constitute risk fac-
tors for RBC transfusion after ICU stay.